GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Gross Profit

Avricore Health (Avricore Health) Gross Profit : $0.74 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Gross Profit?

Avricore Health's gross profit for the three months ended in Dec. 2023 was $0.37 Mil. Avricore Health's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $0.74 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Avricore Health's gross profit for the three months ended in Dec. 2023 was $0.37 Mil. Avricore Health's Revenue for the three months ended in Dec. 2023 was $1.01 Mil. Therefore, Avricore Health's Gross Margin % for the quarter that ended in Dec. 2023 was 36.97%.

Avricore Health had a gross margin of 36.97% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Avricore Health was 51.52%. The lowest was -6.67%. And the median was 32.20%.


Avricore Health Gross Profit Historical Data

The historical data trend for Avricore Health's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Gross Profit Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.34 0.90

Avricore Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.12 0.17 0.19 0.37

Competitive Comparison of Avricore Health's Gross Profit

For the Diagnostics & Research subindustry, Avricore Health's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Gross Profit distribution charts can be found below:

* The bar in red indicates where Avricore Health's Gross Profit falls into.



Avricore Health Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Avricore Health's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=2.598 - 1.701
=0.90

Avricore Health's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=1.009 - 0.636
=0.37

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.74 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Avricore Health's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.37 / 1.009
=36.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Avricore Health  (OTCPK:AVCRF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Avricore Health had a gross margin of 36.97% for the quarter that ended in Dec. 2023 => Competition eroding margins


Avricore Health Gross Profit Related Terms

Thank you for viewing the detailed overview of Avricore Health's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022

Avricore Health Amends Options

By GlobeNewswire GlobeNewswire 09-11-2020

Avricore Health Extends Closing of Placement

By GlobeNewswire GlobeNewswire 07-20-2019

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018

Avricore Health Announces Lifting of Management Cease Trade Order

By Marketwired Marketwired 06-04-2019

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018